Live Breaking News & Updates on Xumin

Stay updated with breaking news from Xumin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) at Upcoming RSNA 2022 Annual Meeting

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced presentations on Axumin (fluciclovine F ....

Mccormick Place , United States , Northwestern University , United Kingdom , Hatice Savas , Kostenloser Wertpapierhandel , Charles Marcus , Clare Gidley , Ismaheel Lawal , Mike Beyer , Priscilla Harlan , Nuclear Medicine Molecular Imaging Prostate Cancer , Department Of Radiology , Nuclear Medicine Molecular Imaging Tuesday Poster Discussion , Emory University , Emory University School Of Medicine , Sam Brown Inc , Bracco Group , Imaging Sciences , A Single Center Comparison Study , Radiological Society Of North America , Division Of Nuclear Medicine , Radiology Sciences , Department Of Imaging , Feinburg School Of Medicine , Nuclear Medicine ,

Blue Earth Diagnostics: Independent Clinical Studies Published Regarding Performance of Axumin (Fluciclovine F 18) PET Imaging in Patients with Recurrent Prostate Cancer Undergoing Androgen Deprivation Therapy (ADT)

- Recently published retrospective studies in Urologic Oncology and Tomography assessed the impact of Androgen Deprivation Therapy (ADT) on Axumin PET imaging - Blue Earth Diagnostics, a Bracco company ....

Loyola University Medical Center , United States , United Kingdom , Nord Trøag , Loyola University , Roberth Wagner , Davide Gauden , Trond Velde Bogsrud , Cara Joyce , Priscilla Harlan , Damian Grybowski , Kostenloser Wertpapierhandel , Clare Gidley , Essam Rashad , Mike Beyer , Medhats Gabriel , Abdulrahman Hashem , Emory University , Drug Administration , Sam Brown Inc , Bracco Group , Nuclear Medicine , Aarhus University Hospital , Corporate Communications , Health Sciences Campus , University Of Arizona College Medicine ,

Blue Earth Diagnostics Highlights Axumin (Fluciclovine F 18) Presentation at Upcoming 22nd Annual Scientific Meeting in Urologic Oncology (SUO)

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced a presentation on Axumin (fluciclovine ....

United Kingdom , Kostenloser Wertpapierhandel , Georgina Mowatt , Geraldl Andriole , Mike Beyer , Priscilla Harlan , Division Of Urologic Surgery , Society Of Urologic Oncology , Alvinj Siteman Cancer Center , Washington University School Of Medicine , Department Of Surgery , Sam Brown Inc , Bracco Group , Nuclear Medicine , Corporate Communications , Blue Earth Diagnostics , Annual Scientific Meeting , Urologic Oncology , Biochemical Recurrence , Prostate Cancer , Data Analysis , Two Prospective Clinical , Urologic Surgery , Cancer Center , Washington University School , Earth Diagnostics ,

Blue Earth Diagnostics Announces Axumin (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the 2021 American Society ....

United States , United Kingdom , Emily Steinberger Weg , Bridgetf Koontz , Rachel Kang , Todd Yezefski , Danielw Lin , Danielh Shevrin , Michael Anthony Carducci , Davida Mankoff , Nathan Conrad , Georgina Mowatt , Yu Hui Chen , Neha Vapiwala , Jing Zeng , Priscilla Harlan , Axumin Fluciclovine , Delphinel Chen , Glenn Liu , Evany Yu , Kostenloser Wertpapierhandel , Volkan Beylergil , Andrea Toulouse , Risa Liang Wong , Fenghai Duan , Sarahk Holt ,

Blue Earth Diagnostics: The Lancet Publishes Results of Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer

(0)
- Treatment informed by Axumin PET imaging significantly improved event-free-survival for men with recurrent prostate cancer at three and four years -
- Winship Cancer Institute of Emory University s EMPIRE-1 trial is first-of-its-kind randomized patient outcomes study of amino acid PET imaging in influencing a cancer control endpoint -
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, is pleased to share news of the publication of a study from researchers at Winship Cancer Institute of Emory University (Winship) evaluating Axumin (fluciclovine F 18) PET imaging in men with recurrent prostate cancer. The randomized, prospective study showed that Axumin-guided post-prostatectomy radiation therapy increased biochemical event-free survival rates in men with recurrent disease. Among 165 patients whose prostate cancer had returned following surgical removal of their prostate, 7 ....

United States , United Kingdom , Emory University , Karenm Xu , Eduard Schreibmann , Davidm Schuster , Omer Kucuk , David Gauden , Josephw Shelton , Asheshb Jani , Mehmeta Bilen , Bradley Carthon , Georgina Mowatt , Olayinkaa Abiodun Ojo , Priscilla Harlan , Preteshr Patel , Mark Goodman , Sherrie Cooper , Bruce Hershatter , Kostenloser Wertpapierhandel , Peterj Rossi , Shreyass Joshi , Subir Goyal , Mike Beyer , Raghuveer Halkar , Winship Cancer Institute Of Emory University ,